Heuristic Capital Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
ProbiusDXprobius.bioin𝕏Aug 2025
Probius develops Quantum Electrochemical Spectroscopy (QES), a label- and reagent-free electrochemical sensing technology that detects and quantifies thousands of analytes—proteins, metabolites, and cells—from microliter-scale biological samples in about 30 minutes.
AI & Machine LearningBiotechDeep TechHardwareHealthtechSemiconductorsFremont, US
Chaitanya Gupta(Executive Officer, Director)inEmmanuel Quevy(Co-founder & CEO)in
Co-investorsCota CapitalSilicon CatalystSocial StartsTSVC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.